|
Q4 2021
Filed on Feb 14, 2022
|
6,682
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
46,862
|
$3.57 - $5.45
$167K - $255K
|
|
Nuance Communications Inc
|
Q4 2021
Filed on Feb 14, 2022
|
16,457
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
49,577
|
$8.38 - $9.95
$415K - $493K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
12,205
|
$35.7 - $39.01
$436K - $476K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
110,677
|
$41.59 - $49.44
$4.6M - $5.47M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
77,068
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
25,432
|
$19.15 - $21.91
$487K - $557K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
26,047
|
$48.8 - $65.64
$1.27M - $1.71M
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
3,916
|
$110.23 - $154.64
$432K - $606K
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
2,683
|
N/A
|
|
|
Q4 2021
Filed on Feb 14, 2022
|
1,141
|
$300.63 - $371.35
$343K - $424K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
11,085
|
$19.68 - $22.51
$218K - $250K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
71,472
|
$3.61 - $5.0
$258K - $357K
|
|
Churchill Capital Corp Iv
|
Q3 2021
Filed on Nov 15, 2021
|
25,506
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2,853
|
$120.37 - $150.62
$343K - $430K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2,342
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
4,063
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
5,487
|
$59.85 - $67.47
$328K - $370K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1,536
|
N/A
|
|
New Oriental Ed & Technology
|
Q3 2021
Filed on Nov 15, 2021
|
289,636
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
2,819
|
$132.13 - $177.45
$372K - $500K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
14,852
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
11,314
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
35,994
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
22,183
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
18,815
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1,667
|
$161.38 - $258.6
$269K - $431K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
8,494
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
28,773
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
9,152
|
$27.8 - $31.44
$254K - $288K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
14,922
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
10,004
|
$3.01 - $4.12
$30.1K - $41.2K
|
|
Minerva Neurosciences Inc
|
Q3 2021
Filed on Nov 15, 2021
|
10,126
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
22,673
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
13,574
|
$0.8 - $1.12
$10.9K - $15.2K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
12,752
|
$9.8 - $10.44
$125K - $133K
|
|
Calithera Biosciences Inc
|
Q3 2021
Filed on Nov 15, 2021
|
16,387
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
16,246
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
13,197
|
N/A
|
|
Pieris Pharmaceuticals Inc
|
Q3 2021
Filed on Nov 15, 2021
|
10,867
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
11,966
|
$2.5 - $3.53
$29.9K - $42.2K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
10,391
|
$1.3 - $2.23
$13.5K - $23.2K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
12,605
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
10,043
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
20,467
|
$1.01 - $1.82
$20.7K - $37.2K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
18,808
|
$0.99 - $1.38
$18.6K - $26K
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
17,721
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
15,213
|
N/A
|
|
|
Q3 2021
Filed on Nov 15, 2021
|
1,396
|
N/A
|
|